VIRGINIA LALIBERTE: Open Payments
NPI 1215414560 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,865 in 158 payments from 45 companies in 2025. Trend: 2023 $3,950 · 2024 $3,739 · 2025 $5,865
Speaker / faculty: $3,000Food & beverage: $2,865
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $3,391 |
| Novartis Pharmaceuticals Corporation | 28 | $336 |
| GlaxoSmithKline, LLC. | 10 | $199 |
| Celgene Corporation | 18 | $171 |
| Daiichi Sankyo Inc. | 6 | $143 |
| Exelixis Inc. | 6 | $116 |
| PFIZER INC. | 6 | $105 |
| Merck Sharp & Dohme LLC | 6 | $104 |
| Janssen Biotech, Inc. | 5 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
Products named: TAGRISSO, IMFINZI, REBLOZYL, OJJAARA, CABOMETYX, KEYTRUDA, Enhertu, KISQALI.
Industry payments across AR — which companies pay providers there.
